To further study the role of SHOC2 in the context of lung tumorigenesis, both shRNA and CRISPR/CAS9 approaches were used to deplete SHOC2 in a panel of human NSCLC cell lines (Supplementary Table 1). The gene discussed is SHOC2; the disease is non-small cell lung carcinoma.